Van beleggers
voor beleggers
desktop iconOne Monitor

Inloggen

  • Geen account? Registreren

Wachtwoord vergeten?

Aandeel Esperite AEX:ESP, NL0009272137

  • 0,037 18 jun 2021 16:39
  • 0,000 (-0,80%) Dagrange 0,036 - 0,038
  • 172.921 Gem. (3M) 791,2K

Nepnieuws van Amar/Esperite

14 Posts
| Omlaag ↓
  1. forum rang 10 DeZwarteRidder 5 augustus 2020 14:06
    Company press releases
    Displaying 21 - 40 of 110 results
    Released Company Title Industry Topic
    01 Jul 2019
    07:17 CEST ESPERITE
    ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
    Biotechnology Alliances and agreements
    30 Jun 2019
    21:01 CEST ESPERITE
    ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
    Biotechnology New
    28 Jun 2019
    23:51 CEST ESPERITE
    Esperite N.V.: Update to the market on the publication of the Annual Report 2018
    Biotechnology New
    25 Jun 2019
    22:59 CEST ESPERITE
    ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
    Biotechnology Other subject
    14 Jun 2019
    08:54 CEST ESPERITE
    ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
    Biotechnology Other subject
    13 Jun 2019
    07:17 CEST ESPERITE
    ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
    Biotechnology Other subject
    04 Jun 2019
    10:18 CEST ESPERITE
    Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
    Biotechnology Other subject
    29 May 2019
    08:26 CEST ESPERITE
    ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
    Biotechnology Other subject
    19 May 2019
    22:54 CEST ESPERITE
    ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
    Biotechnology Other subject
    13 May 2019
    07:17 CEST ESPERITE
    Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
    Biotechnology Other subject
    01 May 2019
    16:58 CEST ESPERITE
    Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018
    Biotechnology Other subject
    05 Apr 2019
    07:17 CEST ESPERITE
    ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
    Biotechnology Other subject
    27 Feb 2019
    07:17 CET ESPERITE
    Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
    Biotechnology Other subject
    26 Feb 2019
    07:17 CET ESPERITE
    ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
    Biotechnology Other subject
    22 Feb 2019
    07:17 CET ESPERITE
    ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
    Biotechnology Other subject
    10 Jan 2019
    07:17 CET ESPERITE
    ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
    Biotechnology Other subject
    30 Nov 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today
    Biotechnology Other subject
    29 Nov 2018
    07:17 CET ESPERITE
    Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates.
    Biotechnology Other subject
    27 Nov 2018
    18:26 CET ESPERITE
    ESPERITE N.V. convenes Annual General Meeting of Shareholders
    Biotechnology Other subject
    23 Nov 2018
    23:35 CET ESPERITE
    ESPERITE (ESP): financial results for 2017 are published.
    Biotechnology Other subject

  2. forum rang 10 DeZwarteRidder 5 augustus 2020 14:09
    Company press releases
    Displaying 41 - 60 of 110 results
    Released Company Title Industry Topic
    19 Nov 2018
    15:35 CET ESPERITE
    ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
    Biotechnology Other subject
    09 Nov 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
    Biotechnology Other subject
    07 Nov 2018
    07:17 CET ESPERITE
    Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
    Biotechnology Other subject
    06 Nov 2018
    08:56 CET ESPERITE
    Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia.
    Biotechnology Other subject
    15 Oct 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
    Biotechnology Other subject
    03 Oct 2018
    18:18 CEST ESPERITE
    Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
    Biotechnology Other subject
    13 Sep 2018
    07:17 CEST ESPERITE
    ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
    Biotechnology Other subject
    31 Aug 2018
    07:17 CEST ESPERITE
    Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
    Biotechnology Other subject
    29 Aug 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
    Biotechnology Other subject
    15 Aug 2018
    07:17 CEST ESPERITE
    Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
    Biotechnology Other subject
    18 Jul 2018
    08:26 CEST ESPERITE
    Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
    Biotechnology Other subject
    02 Jul 2018
    07:17 CEST ESPERITE
    ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).
    Biotechnology Other subject
    28 Jun 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today
    Biotechnology Other subject
    19 Jun 2018
    07:17 CEST ESPERITE
    Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
    Biotechnology Other subject
    18 Jun 2018
    22:24 CEST ESPERITE
    ESPERITE (ESP) further delays publication of Annual Report 2017.
    Biotechnology Other subject
    12 Jun 2018
    07:17 CEST ESPERITE
    European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
    Biotechnology Other subject
    06 Jun 2018
    08:26 CEST ESPERITE
    ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
    Biotechnology Other subject
    05 Jun 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
    Biotechnology Other subject
    17 May 2018
    14:33 CEST ESPERITE
    Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.
    Biotechnology Other subject
    17 May 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today
    Biotechnology Other subject
  3. forum rang 10 DeZwarteRidder 5 augustus 2020 14:10
    Company press releases
    Displaying 61 - 80 of 110 results
    Released Company Title Industry Topic
    16 May 2018
    09:31 CEST ESPERITE
    ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION
    Biotechnology Other subject
    03 May 2018
    11:36 CEST ESPERITE
    Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke
    Biotechnology Other subject
    30 Apr 2018
    12:55 CEST ESPERITE
    ESPERITE NV (ESP) delays publication of Annual Report 2017
    Biotechnology Other subject
    11 Apr 2018
    07:17 CEST ESPERITE
    ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.
    Biotechnology Other subject
    29 Mar 2018
    09:15 CEST ESPERITE
    Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases
    Biotechnology Other subject
    02 Mar 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today
    Biotechnology Other subject
    16 Feb 2018
    07:17 CET ESPERITE
    ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018.
    Biotechnology Other subject
    31 Jan 2018
    13:26 CET ESPERITE
    ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.
    Biotechnology Other subject
    31 Jan 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today
    Biotechnology Other subject
    16 Jan 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today
    Biotechnology Other subject
    10 Jan 2018
    15:07 CET ESPERITE
    ESPERITE (ESP) : transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs
    Biotechnology Other subject
    10 Jan 2018
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today
    Biotechnology Other subject
    08 Jan 2018
    12:59 CET ESPERITE
    ESPERITE (ESP): CEO Frederic Amar converts a portion of his Loan Note into 1.5 million shares.
    Biotechnology Other subject
    05 Jan 2018
    10:56 CET ESPERITE
    ESPERITE (ESP): issues EUR 400'000 convertible note for additional financing provided by CEO Frederic Amar
    Biotechnology Other subject
    22 Dec 2017
    07:17 CET ESPERITE
    ESPERITE (ESP): EUR 1 million of new funding provided by European Select Growth Opportunities Fund until February 23, 2018
    Biotechnology Other subject
    17 Nov 2017
    08:19 CET ESPERITE
    ESPERITE N.V. (ESP) , Stabilisation before growth.
    Biotechnology Other subject
    09 Nov 2017
    08:54 CET ESPERITE
    ESPERITE (ESP) : L1 Capital invests for total EUR 500K today by subscribing to the Tenth tranche (EUR 250K) and shows confidence by investing additionally EUR 250K under the same conditions.
    Biotechnology Other subject
    09 Nov 2017
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions.
    Biotechnology Other subject
    30 Oct 2017
    07:17 CET ESPERITE
    ESPERITE (ESP) : L1 Capital subscribes to the Ninth tranche of investment today
    Biotechnology Other subject
    10 Oct 2017
    08:52 CEST ESPERITE
    ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
    Biotechnology Other subject
  4. forum rang 10 DeZwarteRidder 5 augustus 2020 14:11
    Company press releases
    Displaying 81 - 100 of 110 results
    Released Company Title Industry Topic
    10 Oct 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies
    Biotechnology Other subject
    02 Oct 2017
    07:17 CEST ESPERITE
    ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions.
    Biotechnology Other subject
    29 Sep 2017
    21:16 CEST ESPERITE
    ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting
    Biotechnology Other subject
    31 Aug 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today
    Biotechnology Other subject
    11 Aug 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
    Biotechnology Other subject
    05 Jul 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today
    Biotechnology Other subject
    15 Jun 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today
    Biotechnology Other subject
    01 Jun 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP): L1 Capital subscribes to the second packed tranche today, ahead of schedule
    Biotechnology Other subject
    31 May 2017
    08:52 CEST ESPERITE
    ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
    Biotechnology Other subject
    31 May 2017
    08:26 CEST ESPERITE
    ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
    Biotechnology Other subject
    31 May 2017
    07:57 CEST ESPERITE
    ESPERITE (ESP) Q1 consolidated revenue higher compared to budget
    Biotechnology Other subject
    31 May 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP) has concluded new agreements with its note holders
    Biotechnology Other subject
    23 May 2017
    15:44 CEST ESPERITE
    ESPERITE N.V. convenes Annual General Meeting of Shareholders
    Biotechnology Other subject
    23 May 2017
    07:17 CEST ESPERITE
    ESPERITE (ESP) financial results for 2016 published
    Biotechnology Other subject
    20 May 2017
    18:28 CEST ESPERITE
    Esperite further delays publication of 2016 Annual Report
    Biotechnology Other subject
    19 May 2017
    13:20 CEST ESPERITE
    Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court
    Biotechnology Other subject
    15 May 2017
    10:17 CEST ESPERITE
    Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
    Biotechnology Other subject
    15 May 2017
    10:17 CEST ESPERITE
    Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
    Biotechnology Other subject
    15 May 2017
    07:17 CEST ESPERITE
    Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT)
    Biotechnology Other subject
    15 May 2017
    07:17 CEST ESPERITE
    Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
    Biotechnology Other subject
  5. forum rang 10 DeZwarteRidder 5 augustus 2020 14:11
    Company press releases
    Displaying 101 - 110 of 110 results
    Released Company Title Industry Topic
    11 May 2017
    09:27 CEST ESPERITE
    Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology
    Biotechnology Other subject
    05 May 2017
    09:08 CEST ESPERITE
    Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy
    Biotechnology Other subject
    26 Apr 2017
    07:17 CEST ESPERITE
    ESPERITE delays publication of 2016 Annual Report
    Biotechnology Other subject
    25 Apr 2017
    07:17 CEST ESPERITE
    ESPERITE N.V. (ESP) WITH CRYOSAVE CONTRIBUTES TO TREATING A 9 YEAR OLD CHILD WITH THALASSEMIA MAJOR IN SWITZERLAND
    Biotechnology Other subject
    24 Apr 2017
    07:17 CEST ESPERITE
    ESPERITE's shareholders approved the external financing of up to EUR 13 million
    Biotechnology Other subject
    31 Mar 2017
    22:06 CEST ESPERITE
    CryoSave e Crioestaminal chegaram a um acordo para a armazenagem das células estaminais da Bioteca
    Biotechnology Other subject
    10 Mar 2017
    14:29 CET ESPERITE
    Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million
    Biotechnology Other subject
    08 Mar 2017
    08:26 CET ESPERITE
    Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
    Biotechnology Other subject
    08 Mar 2017
    07:17 CET ESPERITE
    Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies
    Biotechnology Other subject
    28 Feb 2017
    08:55 CET ESPERITE
    Esperite N.V.: Update on Financing
    Biotechnology Other subject
  6. forum rang 10 DeZwarteRidder 5 augustus 2020 15:32
    quote:

    Amarillo schreef op 5 augustus 2020 15:13:


    Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn

    Slimme mensen leren van het verleden.

    Iemand die deze berichten goed leest begrijpt dat hij wordt opgelicht.

    Ik wil newbies een eerlijke kans geven om hun geld al dan niet weg te gooien.
  7. forum rang 10 DeZwarteRidder 6 augustus 2020 08:59
    quote:

    Amarillo schreef op 6 augustus 2020 08:45:


    We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??

    Het is opvallend maar niet verbazingwekkend dat jij nooit ingaat op inhoudelijke zaken m.b.t. Esperite.

    Gelukkig kun je nog terecht in Benidorm, want daar kunnen ze altijd proppers gebruiken.
14 Posts
|Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

Esperite Meer »

Koers 0,037   Verschil 0,00 (-0,80%)
Laag 0,036   Volume 172.921
Hoog 0,038   Gem. Volume 791.215
18 jun 2021 16:39
label premium

Twijfels rond Esperite

Het laatste advies leest u als IEX Premium-lid

Inloggen Ontdek Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links